Panelists discuss how the Port Delivery System (PDS) presents important considerations around adverse effects, patient selection criteria, and adoption challenges including surgical requirements and cost-benefit analyses that must be carefully weighed when …

Chen and colleagues conducted a longitudinal study that included patients with high myopia who were followed for 10 years. Detailed ophthalmic examinations were conducted at the baseline and follow-up visits that included measurements of the BCVA and …

Dec 26, 2024 · As 2024 comes to a close, we here at Ophthalmology Times and the greater Eye Care Network would like to thank you–the reader. Throughout the year, we have had the privilege of covering a wide range of topics in ophthalmology. As always, stay tuned to see highlights from the year from all other Eye Care Brands on Ophthalmology Times.Now, we take a look back at …

Dec 26, 2024 · Key Takeaways. TED involves autoimmune activity targeting orbital tissues, with IL-6 playing a key role in inflammation. Current treatments like teprotumumab address symptoms but not the underlying autoimmune dysregulation.

Oct 23, 2024 · At the 2024 American Academy of Ophthalmology (AAO) meeting, held October 18 to 21 in Chicago, Illinois, ophthalmologists and researchers from around the world convened to share groundbreaking insights on the latest advancements in eye care.

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.

Oct 19, 2024 · Long-term, low-dose antiviral treatment reduces the risk for potentially vision-damaging bouts of inflammation and infection, as well as pain, which occur when shingles affect the eye, according to new research presented October 19 at the American Academy of Ophthalmology’s (AAO) annual meeting in Chicago.

Sep 10, 2024 · Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.

Ophthalmology Times is a physician-driven media brand that presents cutting-edge advancements and analysis from around the world in surgery, clinical diagnosis, therapeutics, device technology, imaging, and gene therapy to elevate the delivery of progressive eye health from physician to patient.